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3.1
Cartilage tissue regeneration 
T.E. Hardingham, S.R. Tew, A.D. Murdoch, United Kingdom 
All tissues in the body contain an extracellular matrix (ECM) that 
provides tissue shape and form and the ECM is an implicit part of 
being multicellular and having specialised tissues and organs to 
carry out different functions. As something labelled “structural” the 
ECM tends to be taken for granted when tissue functions are being 
thought about. However, this belies the fact that the ECM structure 
is essential to support most tissue functions. Support is provided 
CZ TUSPOH ¾CSJMMBS DPNQPOFOUT 	DPMMBHFOT FMBTUJO NJDSP¾CSJMMBS
proteins) with proteoglycan and glycoprotein components to ensure 
tissue hydration and compressive resilience. They together form 
the architectural scaffold of tissues, but the ECM is far from being a 
passive permanent structure for life, as each ECM is dynamic, with 
components being assembled and disassembled all the time. The 
capacity of the ECM for self-renewal is a major factor in tissue repair, 
GPMMPXJOHJOKVSZPSEJTFBTF5IFDBQBDJUZGPSSFQBJSDBOCFJOTVG¾DJFOU
to regenerate healthy tissue, or it can be misdirected to replace 
functional tissue with scar-tissue. The repair of articular cartilage 
QSFTFOUT TPNF WFSZ TQFDJ¾D DIBMMFOHFT 5IJT UJTTVF IBT B MJNJUFE
capacity to repair sites of physical damage. This is largely because 
cartilage lacks blood vessels and blood vessels normally provide the 
route by which new cells arrive at a wound and begin a process of 
damage limitation and provide the cells and signals to initiate repair. 
Cartilage lacks blood vessels because it has a massively developed 
ECM that forms more than 95% of the tissue. It is the integrity of 
this ECM that is essential for the resilient properties of cartilage and 
structures like blood vessels would provide sites of focal weakness 
and thus compromise its function. So cartilage has evolved to be 
avascular and the cells within cartilage, the chondrocytes, thrive 
without being close to blood vessels and indeed they prefer a 
lower oxygen supply for their health and well-being. The health and 
well-being of the chondrocytes is important as they produce and 
slowly turnover the cartilage ECM in our joints all our lives. So to 
regenerate cartilage we need chondrocytes and we need them to 
FG¾DJFOUMZBTTFNCMFBMBSHF&$.UIBUDBOQSPWJEFUIFSFTJMJFOUUJTTVF
to replicate the function of articular cartilage. In these studies we 
JOWFTUJHBUFEUXPNBJOTPVDFTPGDFMMTGPSDBSUJMBHFSFQBJS5IF¾STU
was chondrocytes isolated from human OA knee cartilage removed 
at joint replacement and we assessed their potential to reassemble 
cartilage matrix in vitro with and without transduction with retroviral 
SOX9. The second source of cells investigated was human bone 
marrow stem cells, which are chondrogenic in culture and we 
investigated their matrix forming ability in a a new in vitro culture 
system. 
Methods for chondrocyte isolation from human OA cartilage and 
retroviral transduction with SOX9 and desribed in reference 3 and 
4 and methods for culture of human bone marrow stem cells are 
reported in reference 5. 
)VNBO0"$IPOESPDZUFT5IF¾STUTUSBUFHZXFJOWFTUJHBUFEXBTUP
look at the potential to remake cartilage from the cells isolated from 
tissue removed at joint replacement. It has been established for 
30 years that chondrocytes isolated from cartilage de-differentiate 
in monolayer culture and lose the expression of the ECM proteins 
that characterise the tissue (1). Our strategy was to investigate 
JG BSUJ¾DJBMMZ SFQMBDJOH UIF USBOTDSJQUJPO GBDUPS 409 XIJDI JT
FTTFOUJBM GPS BMM DIPOESPDZUFT 	
 XPVME CF TVG¾DJFOU UP SFUBJO
the chondrocyte phenotype. Chondrocytes were transduced with 
retroviral SOX9 and the answer to the question was both yes and 
no. In monolayer culture the human chondrocytes transduced with 
SOX9 showed a modest increase in the expression of cartilage genes, 
but alone it did not cause a regain of matrix formation (3). However 
when the cells transduced with SOX9 were placed in 3D culture, as 
an aggregate of 500,000 cells, there was an additional increase in 
gene expression and if anabolic growth factors (TGFï¢ and IGF1) were 
added and low oxygen conditions were used, there was, with each 
change in condition, a further increase in ECM gene expression and 
UIFDFMMTDPVMEOPXFG¾DJFOUMZGPSNBDBSUJMBHFMJLFNBUSJYJOXFFLT
culture (4, 5). So the effects of transducing the cells with SOX9 
was to potentiate their response to the other signals, physical and 
biological, that drive chondrocytes to make matrix. Furthermore, the 
results showed that human chondrocytes from an osteoarthritic joint 
could be driven to reform cartilage, which showed that they had not 
lost their capacity to make cartilage ECM due to their disease origin. 
The results also showed that these cells from elderly patients had the 
capacity to expand through many generations in monolayer culture 
and still retain the response to SOX9 transduction. They retained a 
chondrocyte identity throughout this passage in culture, as the same 
409USBOTEVDUJPOUSFBUNFOUBQQMJFEUPTLJO¾CSPCMBTUTEJEOPUUVSO
them into chondrocytes and drive them to make cartilage-like ECM (4). 
These studies carried an important message, that cells from elderly 
patients, even from diseased tissue, were still capable of generating 
new tissue given the appropriate biological signals and this gives 
hope for many strategies for for using existing tissue as a source of 
cells to repair or regenerate cartilage from existing tissue as a source 
of cells. Human Adult Bone Marrow Stem Cells. Sometimes the 
patient supply of cells from cartilage may not be adequate and there 
is great interest in bone marrow stem cells for the repair of cartilage, 
bone and other tissues. Simple protocols to guide the differentiation 
of bone-marrow stem cells into chondrocytes were developed 
almost 10 years ago (6). A key element was to provide a 3D culture 
in which there was a multicellular mass. This was typically achieved 
by forming a cell aggregate by lightly spinning down suspended cells 
into a pellet or by forming a micromass of cells and providing cues 
for differentiation (TGFb3 and dexamethasone). These conditions 
that favour chondrogenic differentiation mimic the mesenchymal 
cell condensation that happens during cartilage formation in early 
embryonic skeletogenesis. This condensation is a critical event in 
laying down the template for long bone formation and marks the 
beginning of the exclusion of blood vessels and nerves from the 
cartilage tissue. Bone marrow derived stem cells respond strongly 
to these conditions in culture and they rapidly grow and secrete and 
assemble a large cartilage-like ECM. We have now investigated this 
system more fully and improved it. The major change was to alter 
UIF DPO¾HVSBUJPOPG DFMM DVMUVSFCZQMBDJOH DFMMT JOB5SBOTXFMMPO
a permeable support as a shallow multicellular layer rather than a 
TQIFSJDBMQFMMFUBOEUIJTQSPWJEFEWFSZFG¾DJFOUOVUSJFOUTVQQMZCPUI
from above and from below. This resulted in much faster growth and 
BTTFNCMZPGUIFDBSUJMBHFBOEUIFDSFBUJPOPGUJTTVFXJUITJHOJ¾DBOU
mechanical properties in 2-4 weeks. The disc of cartilage produced in 
this scaffold-free culture at 2 weeks achieves more than 20 times the 
original mass of the cells at day 0. This rapid growth is accompanied 
CZBWFSZFG¾DJFOUJODPSQPSBUJPOPGGPSFYBNQMFNBKPSDPNQPOFOUT
like aggrecan, into the assembled matrix. This is surprising as the 
surface area to volume ratio is much less for a sphere than a disc, so 
the loss from the matrix based on simple diffusion out of the tissue 
might be expected to be greater from a thin disc. This clearly shows 
UIBUUIFTIBMMPXEJTDGBWPVSTBNPSFFG¾DJFOUBTTFNCMZPGUIF&$.
and it is this which provides an effective barrier to passive diffusion 
of matrix proteins out of the tissue. The newly formed tissue does not 
approach the composition, or properties of cartilage as the collagen 
content is only 2% of the wet weight, whereas in cartilage, collagen 
is more than 20% of the wet weight. However it forms a tissue that is 
surprisingly cohesive in such a short time in culture and clearly shows 
UIFCFOF¾UPGUIFDPNCJOBUJPOPGQIZTJDBMBOECJPMPHJDBMTJHOBMTUP
favour ECM production. This principle would seem to be important 
for any tissue engineering approach to tissue growth in vitro. Indeed 
it would suggest that the current transwell cartilage system might 
be improved further by cyclical loading whilst it is growing, as 
compressive loading is known to enhance matrix production. These 
issues are important in many areas of tissue formation, as the basic 
cohesion of cells into a tissue structure depends on the collagen 
organisation and cross-links to provide a scaffold with tensile 
properties to respond to tissue deformation. It appears unlikely that 
tissue formed in vitro can approach the full properties of mature 
tissue, which has been produced over many years, but it needs to 
SFBDINJOJNVNTUBOEBSETTVG¾DJFOUGPSGVODUJPO5IFJNNBUVSJUZPG
engineered tissue like cartilage may however also be an advantage, 
as it is required to integrate with more mature existing tissue and an 
underdeveloped ECM full of cells pumping out ECM and still in the 
process of formation, may be capable of better tissue integration. 
Much of the strategies in tissue repair may thus focus on providing 
something adequate for immediate purpose, but capable of maturing 
into a stable tissue with long lasting properties. The in vivo biological 
BOECJPNFDIBOJDBMFOWJSPONFOUNBZUIFOQSPWJEFUIF¾OBMESJWFSGPS
tissue adaptation. So providing an engineered tissue that is well 
suited to respond to such signals is an important attribute to build in 
to cell based therapies. 
The application of current cell-based strategies for cartilage repair 
is limited by the relatively high cost of the individual culture of cells 
for each patient. It would be more ideal if such cell-based treatments 
were available from banks of cells for all-patient use. This would 
require the use of allogeneic cells such as stem cells for cartilage 
repair. The experience of tissue and organ transplants is that tissue 
matching is essential to avoid immune rejection, but the evidence 
for cell transplants is less clear and several recent papers on stem 
cells have suggested that they have very low immunogenicity (7, 8). 
It has even been suggested that stem cells may confer some degree 
of tolerance - that the patient once injected with stem cells is made 
tolerant to subsequent exposure to the stem cell progeny that might 
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otherwise be immunogenic. These issues have by no means been 
SFTPMWFE BT JU JT EJG¾DVMU UP EFWJTF OPOIVNBO FYQFSJNFOUT UIBU
provide clear guidance on this issue. However, for many reasons 
cartilage would be a good candidate for trial, as the chondrocytes even 
in an immature ECM, are in an environment devoid of blood vessels 
and away from the circulation that contains the cells necessary to 
initiate an immune response. So it might be expected to be a site 
of low immunogenic risk, requiring minimal immuno-suppression. It 
is therefore an intriguing challenge to establish if stem cells from 
unrelated individuals can be used for the repair of tissues like 
cartilage, as this would open the way to their use on a much broader 
scale because of the economies possible with a banked cell supply; 
but that is a hope for tomorrow and not a promise for today. 
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4.1
Genetically engineered elastin-like polypeptides for cartilage 
tissue regeneration 
L.A. Setton, D.L. Nettles, D.W. Lim, F. Guilak, A. Chilkoti, United 
States of America 
Injectable, in situ forming scaffolds have long been of interest for 
promoting regeneration of focal cartilage defects. With liquid-like 
properties that allow mixing with cells or other factors, these materials 
DBO CF JOKFDUFE UP FOBCMF DPNQMFUF ¾MMJOH PG JSSFHVMBSMZTIBQFE
defects and the delivery of cell or bioactive drugs that could enhance 
integration of newly generated tissue with the existing native tissue. 
Additional advantages are the opportunity for these scaffolds to 
contribute to preservation of mechanical integrity and maintenance 
of cell phenotypes. Many hydrogels capable of in situ formation or 
crosslinking have been evaluated for potential to promote cartilage 
matrix regeneration, including alginate23, poly(ethylene oxide)8,
poly(N-isopropylacrylamide)27 ¾CSJO26, hyaluronic acid21, collagen 
gels18, 33, chitosan7,19, poly(propylene fumarate)28, and poly(vinyl 
alcohol)24. These polymers share the characteristics that they form 
three-dimensional hydrogels in situ of high water content that 
support rounded cell morphologies and rapid diffusion of soluble 
nutrients. However, other properties of these hydrogels differ 
including biocompatibility, degradation, surface interaction, and cell 
recognition characteristics. In situ forming materials also have the 
potential to facilitate tissue regeneration in 2nd and 3rd generation 
procedures for autologous chondrocyte delivery, where various 
biological or polymer membranes or scaffolds have been used to 
preserve retention of the delivered cells6, 14.
Our laboratory has developed a class of polypeptide gels for the 
purpose of promoting cartilage matrix regeneration, biocompatible 
cell delivery, and tissue integration. ELPs consist of oligomeric 
repeats of the pentapeptide sequence Val-Pro-Gly-Xaa-Gly, where 
Xaa is any amino acid except proline30. This is a naturally occurring 
sequence in the protein elastin contained in muscle, ligaments, 
cartilage and numerous other soft tissues. ELPs have been shown 
not to illicit an antibody response upon implantation in multiple 
animal and human applications31, and have been considered to 
be non-immunogenic. ELPs are environmentally responsive, as 
they exhibit a reversible inverse phase transition at a temperature 
(Tt) above which they undergo hydrophobic collapse and form 
intermolecular associations that result in an “aggregated” mass11.
By designing the transition to occur at physiological temperatures, 
the environmental responsiveness of ELPs enables in situ formation 
and physical property changes that contribute to load-bearing and 
cell entrapment3-5. ELPs may be synthesized genetically, and so 
designed at the genetic level to control molecular weight, reactive 
crosslinking sites, and chemistry of the amino acid residues16,17.
In this paper, we review our experience with uncrosslinked and 
crosslinkable ELPs for an ability to entrap chondrocytes and adult 
stem cells, contribute to mechanical load-bearing properties, and 
promote matrix integration in a goat model of osteochondral defect-
¾MMJOH5IFSFTVMUTJMMVTUSBUFUIFGBWPSBCMFDIBSBDUFSJTUJDTBOEGBDJMF
synthesis of an in situ forming, biocompatible hydrogel that can 
assist cartilage matrix regeneration in multiple ways. 
Elastin-Like Polypeptide Gene Design and Synthesis. Genes have 
been designed to encode a wide range of ELP proteins with different 
guest residue sequences and combinations thereof17. For a given 
&-1HFOFTFODPEJOHUIFUBSHFUFEQFOUBQFQUJEFTFRVFODFBSF¾STU
constructed from synthetic oligonucleotides, and oligomerized 
by recursive directional ligation17. In our laboratory, peptides 
IBWF CFFO FYQSFTTFE JO & DPMJ &-1T NBZ CF FBTJMZ QVSJ¾FE CZ
inverse transition cycling. This procedure consists of a series of 
cyclic temperature changes that drive the transitioning of the ELP 
sequence, but not other proteins resulting from the expression. After 
only two sequences of temperature shifts above and below the Tt 
(generally between 28-34°C) the purity of the resulting ELP product 
has been shown to be excellent, with endotoxin levels far below FDA 
allowable limits for medical devices15.
Chondrocyte and Stem Cell Encapsulation for In Vitro Culture. ELPs 
were designed with Val, Gly and Ala in a 5:2:3 ratio, respectively, 
at the guest residue position of the pentapeptide (36 kDa MW). 
These ELPs give rise to a target Tt of 35°C at a solution concentration 
of 50 mg/ml and so enable their use for in situ forming gels at 
physiological temperatures5. Physical characteristics of the ELPs 
were obtained by evaluating the rheological properties above and 
below the Tt using viscometry experiments. Below Tt, the apparent 
viscosity |Ș*| and dynamic shear modulus |G*| were sensitive to ELP 
concentration and exhibited a 2-fold increase in magnitude with a 
4-fold increase in concentration. However, by increasing Tt to 37°C, 
